Dow
     -89.23
12801.23
-0.69%
 |
S&P 500
     -9.31
1342.64
-0.69%
 |
Wil 5K
     -108.90
14000.51
-0.77%
 |
Nasdaq
     -23.35
2903.88
-0.80%
 |
EAFE
     -1.03
53.27
-1.90%
 |
OPEC Oil
     +1.09
116.27
+0.95%
 |
10Y Yield
     +0.01
2.01
+0.42%
October 27, 2008 9:46 PM

Pharma Roundup: Lilly and ImClone Sued, Buyout Spree Still Predicted, and More

By
John Maas
(MoneyWatch)  Pension fund sues over Lilly/ImClone deal -- The State-Boston Retirement System of Massachusetts, along with several other ImClone shareholders, claims in the suit that the $70 Lilly paid per share was too low. [Source: Pharmalot]

Pharma buyouts of biotech close? -- Predictions are flying that pharma companies are about to embark on a buying spree of biotech firms, fueled by credit woes for biotech funding. The Philadelphia Inquirer joins the speculation. [Source: FiercePharma]

On a similar note... -- In London, the "Genomics and Society: Reinventing Life?" conference has warned the world that biotech's funding woes mean new medicines are less likely. [Source: Medical News Today]

© 2008 CBS Interactive Inc.. All Rights Reserved.
.
Scroll Left
Scroll Right More »
CBS News on Facebook
  • Building You a Better Morning

  • CBS This Morning

    "CBS This Morning," anchored by Charlie Rose, Gayle King and Erica Hill, airs weekdays from 7 to 9 a.m. ET and at the same time in other time zones.
    Learn more...